AT1 receptor is expressed in several human cancer cell lines including pancreatic and prostate cancer cell lines [46, 47] and in a subpopulation of ER-positive, ERBB2-negative breast cancer cases [48], and ARB treatment suppressed AT1 receptor-positive cancer cell proliferation and tumor growth. Here, AGTR1 is linked to breast carcinoma.